ALZHEIMER BLOOD BIOMARKERS
Clinical trials for ALZHEIMER BLOOD BIOMARKERS explained in plain language.
Never miss a new study
Get alerted when new ALZHEIMER BLOOD BIOMARKERS trials appear
Sign up with your email to follow new studies for ALZHEIMER BLOOD BIOMARKERS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Hope for down syndrome: drug may stop Alzheimer's seizures
Prevention Recruiting nowThis study tests if the drug levetiracetam can prevent epileptic seizures in 120 adults over 40 with Down syndrome and Alzheimer's disease. Participants will receive either the drug or a placebo for 96 weeks. The goal is to see if the drug can stop seizures and possibly slow brai…
Matched conditions: ALZHEIMER BLOOD BIOMARKERS
Phase: PHASE3 • Sponsor: Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau • Aim: Prevention
Last updated Jun 27, 2026 08:10 UTC
-
Could insulin jabs boost brain power in Alzheimer's?
Symptom relief Recruiting nowThis study is testing whether giving insulin through a vein every five minutes for two hours, once a week for six months, can improve how the body uses sugar and how well people with Alzheimer's think. Eight adults with mild to moderate Alzheimer's will take part. The goal is to …
Matched conditions: ALZHEIMER BLOOD BIOMARKERS
Phase: NA • Sponsor: Pennington Biomedical Research Center • Aim: Symptom relief
Last updated Jun 27, 2026 08:01 UTC